ICCM today
$0.70-$0.05 (-7.24%)close Nov 12, 2026Trend
DailyDowntrend (confirmed)
4 hourStrong Bearish
1 hourSymmetric Triangle
15 minLeaning Bullish
5 minConsolidating
Daily trend turns up above $9.54
Key levels
Resistance$1.09
Resistance$0.96
Latest news & SEC filings
ProductIceCure Medical secures Chinese patent for connector used in freezing systems
NewsIceCure Medical wins China patent for a part in its cryogenic system
All ICCM news →About IceCure Medical
IceCure Medical is an Israeli medical device company that develops cryoablation systems for destroying tumors by freezing them. Its main product is the ProSense system, which uses liquid nitrogen and disposable CryoProbes to treat benign and malignant tumors in organs such as breasts, lungs, kidneys, and bones, and it is also used to freeze nerves for pain relief. The company sells its systems and single-use probes to hospitals, clinics, and distributors, and has regulatory approvals in the United States, Europe, Asia, and other regions.
Based on the company's 20-F filed Mar 17, 2026.
Nasdaq · Healthcare
IceCure Medical Ltd. (ICCM)
What Is the Price Target for ICCM?
SEPT Low Target
$1.00
SEPT Mid Target
$1.00
SEPT High Target
$1.00
Analyst Consensus
$1.00
Is ICCM a Buy or Sell Right Now?
Thesis
- •Revenue growing 2.7% YoY with SLOWING trend — consistent growth.
- •SEC filings signal active product innovation — 1 new product/expansion keywords detected in 10-K. R&D investment rising.
AI-Powered Trading Signals
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for ICCM.
Start Free Trial →Is ICCM Overvalued or Undervalued?
Valuation Verdict
UNDERVALUED
Methods Used
Analyst Consensus
Fair Value
$1.00
13
Moat Score
NONE
3/9
Piotroski Score
N/A
Altman Z-Score
What Is Smart Money Doing with ICCM?
Insider Signal
NEUTRAL
0 buys / 0 sells (90d)
Congress Signal
NEUTRAL
0 buys / 0 sells (90d)
Institutional
N/A
Short Squeeze Risk
LOW
Signal: NEUTRAL
Track Smart Money Across 4,000+ Stocks
Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.
See All Smart Money Signals →ICCM Growth Story
Revenue YoY
2.7%
3yr Revenue CAGR
3.1%
EPS Growth YoY
-20%
FCF Growth YoY
-15.6%
Revenue Trend
SLOWING
Dark Pool Trades for ICCM
PREVIEWSEPT Investing tracks real-time dark pool institutional trades for ICCM, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.
| Time | Price | Size | Value | Side |
|---|---|---|---|---|
| 23:01:48 | $0.70 | 1,400 | $$980 | SELL |
| 21:50:16 | $0.67 | 1,140 | $$764 | SELL |
| 19:28:26 | $0.71 | 1,000 | $$706 | BUY |
| 17:28:02 | $0.70 | 1,016 | $$711 | SELL |
| 17:26:50 | $0.71 | 4,700 | $$3K | BUY |
5 dark pool trades shown · $$6K preview volume
Real-time institutional flow, block trades, and net positioning
Full AI Research Report
SEPT's Trading AI has generated a free, downloadable PDF research report for IceCure Medical Ltd. (ICCM) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.
Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...
AI-Powered Trading Signals.
Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.
Try SEPT Free for 7 Days →ICCM — frequently asked questions
What is ICCM stock price today?
IceCure Medical Ltd. (ICCM) is at $0.70, down 7.24% (-$0.05) at the Nov 12, 2026 close.
Why is ICCM stock moving today?
Latest ICCM news — Nov 11, 2026: IceCure Medical secures Chinese patent for connector used in freezing systems · Nov 9, 2026: IceCure Medical wins China patent for a part in its cryogenic system
What is the ICCM price target?
The average analyst price target for ICCM is $1.00, ranging from $1 to $1, based on 1 analysts. Latest: Maxim Group maintains on May 14, 2026.
What do analysts rate ICCM?
Analyst ratings for ICCM: 0 Buy, 1 Hold, 0 Sell — consensus Hold.
Did ICCM beat earnings?
ICCM last reported on Aug 12, 2026: EPS -$1.54 vs -$1.52 expected — a miss of 1.3%.
Does ICCM pay a dividend?
ICCM does not currently pay a dividend.
What are ICCM support and resistance levels?
Resistance: $0.96, $1.09, $2.12.
What are insiders doing with ICCM?
Insider activity: NEUTRAL, 0 buys and 0 sells in the last 90 days.
What is the latest news on ICCM?
Nov 11, 2026: IceCure Medical secures Chinese patent for connector used in freezing systems · Nov 9, 2026: IceCure Medical wins China patent for a part in its cryogenic system